{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:41:27Z","timestamp":1791477687842,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11655-026-3846-0","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:28:39Z","timestamp":1778650119000},"page":"702-708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Berberine Regulates Hepatic Fatty Acid Metabolism via AMPK\/SIRT1\/PGC-1\u03b1 Pathway"],"prefix":"10.1007","volume":"32","author":[{"given":"Yu-jin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-min","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-er","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"3846_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology 2020;158:1851\u20131864.","journal-title":"Gastroenterology"},{"key":"3846_CR2","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/hep.29546","volume":"67","author":"AM Allen","year":"2018","unstructured":"Allen AM, Therneau TM, Larson JJ, Coward A, Somers VK, Kamath PS. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year-community study. Hepatology 2018;67:1726\u20131736.","journal-title":"Hepatology"},{"key":"3846_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology 2020;71:1851\u20131864.","journal-title":"Hepatology"},{"key":"3846_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","volume":"14","author":"H Tilg","year":"2017","unstructured":"Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol 2017;14:32\u201342.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3846_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments. Nat Rev Gastroenterol Hepatol 2021;18:599\u2013612.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3846_CR6","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675\u20131685.","journal-title":"N Engl J Med"},{"key":"3846_CR7","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"MV Machado","year":"2016","unstructured":"Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 2016;150:1769\u20131777.","journal-title":"Gastroenterology"},{"key":"3846_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.plefa.2010.02.012","volume":"82","author":"CD Byrne","year":"2010","unstructured":"Byrne CD. Fatty liver: role of inflammation and fatty acid nutrition. Prostaglandins Leukot Essent Fatty Acids 2010;82:265\u2013271.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"3846_CR9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada P, Gonz\u00e1lez-Rodr\u00edguez \u00c1, Garc\u00eda-Monz\u00f3n C, Valverde \u00c1M. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis 2020;11:802.","journal-title":"Cell Death Dis"},{"key":"3846_CR10","doi-asserted-by":"publisher","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","volume":"161","author":"IR Schlaepfer","year":"2020","unstructured":"Schlaepfer IR, Joshi M. CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential. Endocrinology 2020;161:bqz046.","journal-title":"Endocrinology"},{"key":"3846_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.tem.2017.10.003","volume":"28","author":"AL Am","year":"2017","unstructured":"AM AL, Syed DN, Ntambi JM. Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism. Trends Endocrinol Metab 2017;28:831\u2013842.","journal-title":"Trends Endocrinol Metab"},{"key":"3846_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 2018;19:121\u2013135.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3846_CR13","doi-asserted-by":"publisher","first-page":"G979","DOI":"10.1152\/ajpgi.00169.2012","volume":"303","author":"EM Morris","year":"2012","unstructured":"Morris EM, Meers GM, Booth FW, Fritsche KL, Hardin CD, Thyfault JP, et al. PGC-1\u03b1 overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion. Am J Physiol Gastrointest Liver Physiol 2012;303:G979\u2013G992.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3846_CR14","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","volume":"9","author":"X Feng","year":"2019","unstructured":"Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics 2019;9:1923\u20131951.","journal-title":"Theranostics"},{"key":"3846_CR15","doi-asserted-by":"publisher","first-page":"2074610","DOI":"10.1155\/2021\/2074610","volume":"2021","author":"J Guo","year":"2021","unstructured":"Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev 2021;2021:2074610.","journal-title":"Oxid Med Cell Longev"},{"key":"3846_CR16","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.3390\/molecules26237368","volume":"26","author":"A Rauf","year":"2021","unstructured":"Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, et al. Berberine as a potential anticancer agent: a comprehensive review. Molecules 2021;26:7368.","journal-title":"Molecules"},{"key":"3846_CR17","doi-asserted-by":"publisher","first-page":"1015045","DOI":"10.3389\/fphar.2022.1015045","volume":"13","author":"W Xie","year":"2022","unstructured":"Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol 2022;13:1015045.","journal-title":"Front Pharmacol"},{"key":"3846_CR18","doi-asserted-by":"publisher","first-page":"110984","DOI":"10.1016\/j.biopha.2020.110984","volume":"133","author":"X Xu","year":"2021","unstructured":"Xu X, Yi H, Wu J, Kuang T, Zhang J, Li Q, et al. Therapeutic effect of berberine on metabolic diseases: both pharmacological data and clinical evidence. Biomed Pharmacother 2021;133:110984.","journal-title":"Biomed Pharmacother"},{"key":"3846_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3389\/fphar.2020.01225","volume":"11","author":"C Iside","year":"2020","unstructured":"Iside C, Scafuro M, Nebbioso A, Altucci L. SIRT1 activation by natural phytochemicals: an overview. Front Pharmacol 2020;11:1225.","journal-title":"Front Pharmacol"},{"key":"3846_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.phymed.2018.09.212","volume":"50","author":"J Ju","year":"2018","unstructured":"Ju J, Li J, Lin Q, Xu H. Efficacy and safety of berberine for dyslipidaemias: a systematic review and meta-analysis of randomized clinical trials. Phytomedicine 2018;50:25\u201334.","journal-title":"Phytomedicine"},{"key":"3846_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s11658-019-0158-9","volume":"24","author":"Z Ren","year":"2019","unstructured":"Ren Z, He H, Zuo Z, Xu Z, Wei Z, Deng J. The role of different SIRT1-mediated signaling pathways in toxic injury. Cell Mol Biol Lett 2019;24:36.","journal-title":"Cell Mol Biol Lett"},{"key":"3846_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-0032-1328321","volume":"79","author":"H Dong","year":"2013","unstructured":"Dong H, Zhao Y, Zhao L, Lu F. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med 2013;79:437\u2013446.","journal-title":"Planta Med"},{"key":"3846_CR23","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1038\/ncomms6493","volume":"5","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Zhang H, Li B, Meng X, Wang J, Zhang Y, et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat Commun 2014;5:5493.","journal-title":"Nat Commun"},{"key":"3846_CR24","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.7150\/ijbs.62556","volume":"17","author":"Y Xu","year":"2021","unstructured":"Xu Y, Yu T, Ma G, Zheng L, Jiang X, Yang F, et al. Berberine modulates deacetylation of PPAR-\u03b1 to promote adipose tissue remodeling and thermogenesis via AMPK\/SIRT1 pathway. Int J Biol Sci 2021;17:3173\u20133187.","journal-title":"Int J Biol Sci"},{"key":"3846_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","volume":"141","author":"X Zhu","year":"2019","unstructured":"Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, et al. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Free Radic Biol Med 2019;141:192\u2013204.","journal-title":"Free Radic Biol Med"},{"key":"3846_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jare.2021.07.011","volume":"37","author":"C Wu","year":"2022","unstructured":"Wu C, Zhao Y, Zhang Y, Yang Y, Su W, Yang Y, et al. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR\u2019s cholesterol-decreasing efficacy in patients. J Adv Res 2022;37:197\u2013208.","journal-title":"J Adv Res"},{"key":"3846_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2020.07.028","volume":"159","author":"S Yao","year":"2020","unstructured":"Yao S, Yuan Y, Zhang H, Meng X, Jin L, Yang J, et al. Berberine attenuates the abnormal ectopic lipid deposition in skeletal muscle. Free Radic Biol Med 2020;159:66\u201375.","journal-title":"Free Radic Biol Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-3846-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-3846-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-3846-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T13:47:13Z","timestamp":1784987233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-3846-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3846"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-3846-0","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"16 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}